CDC Escalates Ebola Response Amid Growing Bundibugyo Outbreak in DRC and Uganda

The U.S. Centers for Disease Control and Prevention has intensified its response to a rapidly expanding Ebola disease outbreak caused by the Bundibugyo virus strain in the Democratic Republic of the Congo (DRC) and neighboring Uganda. Official reports confirm the outbreak, declared on May 15, 2026, has led to over 1,200 confirmed cases and more than 300 deaths in the DRC alone by late June, with additional cases and fatalities reported in Uganda.[1][1]

The World Health Organization declared the event a Public Health Emergency of International Concern (PHEIC) on May 17, 2026, citing unusual clusters of deaths, healthcare worker infections, and risks of amplification in health facilities.[2] CDC activated a public health emergency response the same day, issuing Level 3 travel notices for affected DRC provinces (Ituri, North Kivu, South Kivu) and Level 1 for Uganda, while deploying staff for surveillance, laboratory support, and exit screening.[3][4]

This marks the largest recorded Bundibugyo outbreak, distinct from Zaire ebolavirus strains due to the absence of approved vaccines or specific treatments. Historical mortality for Bundibugyo ranges 25-50%. Efforts are underway via BARDA and partners to develop countermeasures, including monoclonal antibodies and vaccine candidates.[5]

ECDC and MSF reports highlight ongoing challenges, including case surges, isolation of hundreds of patients, and the need for sustained interventions. No cases have reached the United States, with transmission risk assessed as low due to the requirement for direct contact with bodily fluids.[1][6]

Modeling from CDC's MMWR suggests potential for larger spread without aggressive isolation measures, underscoring the urgency despite official emphasis on contained U.S. risk. The outbreak's scale—now the third-largest Ebola event on record—has drawn coordinated international action from WHO, Africa CDC, and NGOs, though general media attention has varied.[7]